| [1] |
LAN Yu, WANG Fenghua.
Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO
[J]. China Oncology, 2025, 35(2): 219-227.
|
| [2] |
WANG Ting, QIN Yi, XU Xiaowu, YU Xianjun.
New advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2024
[J]. China Oncology, 2025, 35(1): 1-11.
|
| [3] |
CHEN Hong, CAO Zhiyun.
Recent progress in the construction and application of patient-derived pancreatic cancer organoid models
[J]. China Oncology, 2024, 34(6): 590-597.
|
| [4] |
Urologic Chinese Oncology Group.
Expert consensus on early diagnosis and treatment of bladder cancer (2024 edition)
[J]. China Oncology, 2024, 34(6): 607-618.
|
| [5] |
REN Jiaqiang, WU Shuai, SU Tong, LI Jie, HAN Liang, WU Zheng.
An exploratory study of INPP4B, a biomarker of gemcitabine chemoresistance in pancreatic cancer
[J]. China Oncology, 2024, 34(12): 1090-1099.
|
| [6] |
TAN Xiaolang, YAO Sha, WANG Guihua, PENG Luogen.
Research on uPAR promoting proliferation, migration, and chemoresistance of pancreatic cancer by inhibiting autophagy via MAPK signaling
[J]. China Oncology, 2024, 34(10): 944-956.
|
| [7] |
LI Tianjiao, YE Longyun, JIN Kaizhou, WU Weiding, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2023
[J]. China Oncology, 2024, 34(1): 1-12.
|
| [8] |
LI Tong, YANG Huijuan.
Progress in diagnosis and treatment of mucinous ovarian cancer
[J]. China Oncology, 2024, 34(1): 90-96.
|
| [9] |
CD-Positive Lymphoma Pathology Expert Group.
The standardization of immunohistochemical detection and interpretation of CD30 expression in lymphomas
[J]. China Oncology, 2023, 33(3): 228-234.
|
| [10] |
ZENG Cheng, ZHANG Jian.
Leading research progress and prospect of antibody-drug conjugate in pancreatic cancer in 2022
[J]. China Oncology, 2023, 33(3): 235-240.
|
| [11] |
FU Qingsheng, JIN Lei, ZHANG Xudong, XU Yingchen, ZHU Chunfu, QIN Xihu, WU Baoqiang.
Effect of tRF-Pro-CGG on the biological behavior of mouse pancreatic cancer cells and its molecular mechanism
[J]. China Oncology, 2023, 33(3): 241-249.
|
| [12] |
Energizing Specialty Construction-Multidisciplinary Expert Committee for Creating Healthy China, The Society of Breast Cancer China Anti-Cancer Association.
Standardization of multi disciplinary team treatment for breast cancer (2023 edition)
[J]. China Oncology, 2023, 33(12): 1188-1203.
|
| [13] |
YUE Ming, WANG Liwei, CUI Jiujie.
Research progress on the mechanism of organ-specific lung metastasis in pancreatic cancer
[J]. China Oncology, 2023, 33(11): 1026-1031.
|
| [14] |
JIA Yuming, YE Zeng, DENG Yanli, LI Shengchao, ZHANG Zhilei, WANG Chao, XU Xiaowu, QIN Yi, PENG Li.
The research on FBW7 gene enhances antitumor effect of paclitaxel on pancreatic cancer through GSDME-mediated pyroptosis
[J]. China Oncology, 2023, 33(10): 889-897.
|
| [15] |
WANG Xu, CHENG He, LIU Chen, YU Xianjun.
New progress in basic research, clinical diagnosis and treatment of pancreatic cancer in 2022
[J]. China Oncology, 2023, 33(1): 1-13.
|